HUTCHMED (CHINA) LIMITED - AMERICAN DEPOSITARY SHA
16.36
18-April-24 15:59:58
15 minutes delayed
Stocks
-0.09
-0.55%
Today's range
16.07 - 16.53
ISIN
N/A
Source
NASDAQ
-
HUTCHMED Reports 2023 Interim Results and Provides Business Updates
31 Jul 2023 07:41:53 By Nasdaq GlobeNewswire
-
HUTCHMED Announces Changes to Board of Directors and Technical Committee
13 Jul 2023 04:30:00 By Nasdaq GlobeNewswire
-
09 Jul 2023 20:00:00 By Nasdaq GlobeNewswire
-
HUTCHMED to Announce 2023 Half-Year Financial Results
26 Jun 2023 04:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet
15 Jun 2023 20:30:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 10:30:00 By Nasdaq GlobeNewswire
-
09 Jun 2023 05:30:00 By Nasdaq GlobeNewswire
-
25 May 2023 19:00:54 By Nasdaq GlobeNewswire
-
HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting
25 May 2023 18:00:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces Board of Directors and Board Committee Membership
12 May 2023 04:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committees
10 May 2023 04:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
17 Apr 2023 20:00:00 By Nasdaq GlobeNewswire
-
HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
11 Apr 2023 20:00:00 By Nasdaq GlobeNewswire
-
Intended Retirement of Independent Non-executive Director
11 Apr 2023 04:30:00 By Nasdaq GlobeNewswire
-
04 Apr 2023 05:30:00 By Nasdaq GlobeNewswire
-
30 Mar 2023 20:00:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China
14 Mar 2023 09:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED Confirms No Assets Held at Silicon Valley Bank
12 Mar 2023 20:07:31 By Nasdaq GlobeNewswire
-
HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
28 Feb 2023 03:30:00 By Nasdaq GlobeNewswire